Cargando…
Foetal vascular responses to thromboxane receptor blockade
We hypothesized that foetal administration of SQ-29,548, a putative thromboxane receptor blocker, would prevent foeto–placental vasoconstriction produced by the thromboxane mimic U46619. Arterial blood gases, continuous monitoring of maternal and foetal heart rates and blood pressures were performed...
Autores principales: | Meyer, B. A., Dickinson, J. E., Walsh, S. W., Parisi, V. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365321/ https://www.ncbi.nlm.nih.gov/pubmed/18475435 http://dx.doi.org/10.1155/S0962935192000048 |
Ejemplares similares
-
Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer
por: Watkins, Gareth, et al.
Publicado: (2005) -
Thromboxane Modulates Endothelial Permeability
por: Klausner, J. M., et al.
Publicado: (1994) -
Stability of thromboxane in blood samples
por: Helgadóttir, Helga, et al.
Publicado: (2019) -
Investigation of a Thromboxane A(2) Receptor–Based Vaccine for Managing Thrombogenesis
por: Alshbool, Fatima Z., et al.
Publicado: (2018) -
Antagonism of the Thromboxane‐Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy
por: West, James D., et al.
Publicado: (2019)